Want to dive into Scott Alexander's work and his thousands of blog posts? This fan website lets you sort and do semantic search through the whole codex. Enjoy!
| Date | ||
| Length | ||
| Likes | ||
| Comments |
Scott Alexander argues that the 33% rate of post-marketing safety events for FDA-approved drugs is not necessarily concerning and explains why post-marketing surveillance is a normal part of drug safety monitoring.
Read Scott like a free app: tap then Add to Home Screen. Read Scott like a free app: tap then Add app to Home screen. Add Read Scott Alexander to your home screen to read it like an app.